Arq Bras Endocrinol Metab 2011;55(5):353-354
Metabolic improvement by telmisartan beyond angiotensin receptor blockade: role of adipokines
DOI: 10.1590/S0004-27302011000500010
DOI: 10.1590/S0004-27302011000500010
Flow diagram of patient exclusion criteria for SNMTC and FNMTC groups.
Sahebkar A. Metabolic improvement by telmisartan beyond angiotensin receptor blockade: role of adipokines. Arq Bras Endocrinol Metab 2011;55(5):353-4.
Sahebkar, Amirhossein. Metabolic improvement by telmisartan beyond angiotensin receptor blockade: role of adipokines. Arq Bras Endocrinol Metab, v. 55, n. 5, p. 353-354, Jun. 2011.
Sahebkar, A. (2011). Metabolic improvement by telmisartan beyond angiotensin receptor blockade: role of adipokines. Arq Bras Endocrinol Metab, 55(5), 353-354.
Sahebkar, Amirhossein. Metabolic improvement by telmisartan beyond angiotensin receptor blockade: role of adipokines. Arq Bras Endocrinol Metab [online]. 2011, vol. 55, n. 5, [cited 2026-03-08], pp.353-354. Available from: <https://www.aem-sbem.com/article/metabolic-improvement-by-telmisartan-beyond-angiotensin-receptor-blockade-role-of-adipokines/>. ISSN 2359-3997.